Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Biotechnology Value Fund, L.P. -- Ignore unavailable to you. Want to Upgrade?

To: nigel bates who wrote (2090)	11/6/2000 10:36:01 PM
From: scaram(o)uche	Read Replies (1) \| Respond to of 4974

endless supply of bucks....... Monday November 6, 7:13 pm Eastern Time Press Release SOURCE: Ribozyme Pharmaceuticals, Inc. RPI Files Shelf Registration and Restates 2nd Quarter Earnings BOULDER, Colo., Nov. 6 /PRNewswire/ -- Ribozyme Pharmaceuticals, Inc. (RPI) (Nasdaq: RZYM - news) announced today that it has filed a shelf registration statement with the Securities and Exchange Commission covering an aggregate of 3,000,000 shares of its common stock. The registration statement has not yet been declared effective, and the securities may not be sold nor may offers to buy be accepted prior to the time the registration statement becomes effective. (snip)